Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma.
Takuma NakatsukaHayato NakagawaYuki HayataTaijiro WakeTomoharu YamadaMizuki Nishibatake KinoshitaRyo NakagomiMasaya SatoTatsuya MinamiKoji UchinoKenichiro EnookuYotaro KudoYasuo TanakaTakahiro KishikawaMotoyuki OtsukaRyosuke TateishiKazuhiko KoikePublished in: Journal of gastroenterology (2021)
Post-treatment cfDNA analysis may facilitate the construction of biomarkers for predicting MTA treatment effects.
Keyphrases